{"created_at":"Mon Dec 01 09:10:27 +0000 2014","id":539345773671251968,"id_str":"539345773671251968","text":"RT @fwpharma: Novartis' Gilenya fails in primary progressive multiple sclerosis study http:\/\/t.co\/Ho4aoRaszU $NVS #pharma","source":"\u003ca href=\"http:\/\/hockeystickweekly.com\" rel=\"nofollow\"\u003edenbot\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":432886514,"id_str":"432886514","name":"Dieter Laevers","screen_name":"FightTheFake","location":"Brussels","url":"http:\/\/www.inxites.be","description":"CEO of InXites and fighting the fake all together","protected":false,"verified":false,"followers_count":418,"friends_count":321,"listed_count":25,"favourites_count":2404,"statuses_count":5032,"created_at":"Fri Dec 09 22:07:33 +0000 2011","utc_offset":3600,"time_zone":"Brussels","geo_enabled":true,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/486898806449922048\/pk0mBgW0_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/486898806449922048\/pk0mBgW0_normal.png","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/432886514\/1404994294","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Mon Dec 01 09:07:43 +0000 2014","id":539345084521930752,"id_str":"539345084521930752","text":"Novartis' Gilenya fails in primary progressive multiple sclerosis study http:\/\/t.co\/Ho4aoRaszU $NVS #pharma","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":35789155,"id_str":"35789155","name":"FirstWord Pharma","screen_name":"fwpharma","location":"","url":"http:\/\/firstwordpharma.com","description":"The latest global #pharma news, insights, analysis, and views providing you with an information edge.  FirstWord Pharma. Where people who know first, go first.","protected":false,"verified":false,"followers_count":22630,"friends_count":547,"listed_count":587,"favourites_count":12,"statuses_count":18741,"created_at":"Mon Apr 27 16:44:14 +0000 2009","utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"305F8E","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"666666","profile_sidebar_fill_color":"EFEFEF","profile_text_color":"333333","profile_use_background_image":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/1811310207\/FW_Pharma_Twitter_normal.jpg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/1811310207\/FW_Pharma_Twitter_normal.jpg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/35789155\/1407427188","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":2,"favorite_count":0,"entities":{"hashtags":[{"text":"pharma","indices":[100,107]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/Ho4aoRaszU","expanded_url":"http:\/\/www.firstwordpharma.com\/node\/1249091","display_url":"firstwordpharma.com\/node\/1249091","indices":[72,94]}],"user_mentions":[],"symbols":[{"text":"NVS","indices":[95,99]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"pharma","indices":[114,121]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/Ho4aoRaszU","expanded_url":"http:\/\/www.firstwordpharma.com\/node\/1249091","display_url":"firstwordpharma.com\/node\/1249091","indices":[86,108]}],"user_mentions":[{"screen_name":"fwpharma","name":"FirstWord Pharma","id":35789155,"id_str":"35789155","indices":[3,12]}],"symbols":[{"text":"NVS","indices":[109,113]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en","timestamp_ms":"1417425027660"}
